FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Kottakis

Research Profile

Chemicals & Drugs

Phenomena

Procedures

Disorders

Devices

Nebulizers and Vaporizers

Concepts & Ideas

Co-author Network

Publications

TOP 3
Alexander G Chuchalin; Ahmed I Manjra; Nadezhda N Rozinova; Olga Skopková; Giovanni Della Cioppa; Denise Till; Guenther Kaiser; Taiwo Fashola; John Kottakis
Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
J F Muir; D Benhamou; Antoine CUVELIER; Vincent Le Gros; Tim Overend; Denise Till; Giovanni Della Cioppa; John Kottakis
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease.
Demosthenes Bouros; John Kottakis; Vincent Le Gros; Tim Overend; Giovanni Della Cioppa; Nikolaos Siafakas
Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Kottakis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Alexander G Chuchalin; Ahmed I Manjra; Nadezhda N Rozinova; Olga Skopková; Giovanni Della Cioppa; Denise Till; Guenther Kaiser; Taiwo Fashola; John Kottakis
Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2005;18(1):63-73.
2004: J F Muir; D Benhamou; Antoine CUVELIER; Vincent Le Gros; Tim Overend; Denise Till; Giovanni Della Cioppa; John Kottakis
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease.
International journal of clinical practice 2004;58(5):457-64.
2004: Demosthenes Bouros; John Kottakis; Vincent Le Gros; Tim Overend; Giovanni Della Cioppa; Nikolaos Siafakas
Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility.
Current medical research and opinion 2004;20(5):581-6.
2004: R Dahl; J P Creemers; Jan A van Noord; A Sips; Giovanni Della Cioppa; M Thomson; K Andriano; John Kottakis; Taiwo Fashola
Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
Respiration; international review of thoracic diseases 2004;71(2):126-33.
2004: Edwin A Bronsky; Jay Grossman; Marc J Henis; Paul P Gallo; Umit Yegen; Giovanni Della Cioppa; John Kottakis; Sunil Mehra
Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults.
Current medical research and opinion 2004;20(2):131-7.
2002: Gail S Shapiro; Umit Yegen; Jim Xiang; John Kottakis; Giovanni Della Cioppa
A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterol.
Clinical therapeutics 2002;24(12):2077-87.
2002: Mitchell Friedman; Giovanni Della Cioppa; John Kottakis
Formoterol therapy for chronic obstructive pulmonary disease: a review of the literature.
Pharmacotherapy 2002;22(9):1129-39.
2002: Andrea Rossi; Peter Kristufek; Bernard E Levine; Moira H Thomson; Denise Till; John Kottakis; Giovanni Della Cioppa
Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
Chest 2002;121(4):1058-69.
2002: John Kottakis; Giovanni Della Cioppa; Jacques Creemers; Louis Greefhorst; Violette Lecler; Riccardo Pistelli; Tim Overend; Denise Till; G nter Rapatz; Vincent Le Gros; Demosthenes Bouros; Nikolaos Siafakas
Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study.
Canadian respiratory journal : journal of the Canadian Thoracic Society 2002;9(2):107-15.
2002: David S Pearlman; John Kottakis; Denise Till; Giovanni Della Cioppa
Formoterol delivered via a dry powder inhaler (Aerolizer): results from long-term clinical trials in children.
Current medical research and opinion 2002;18(8):445-55.
2001: D Benhamou; Antoine CUVELIER; J F Muir; V Leclerc; Vincent Le Gros; John Kottakis; Isabelle Bourdeix
Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk).
Respiratory medicine 2001;95(10):817-21.
2001: John Kottakis; R Wood; Vincent Le Gros; Giovanni Della Cioppa
Clinical efficacy with formoterol in the absence of a response to salmeterol: a review.
International journal of clinical practice 2001;55(7):476-9.
2001: A D D'Urzo; M C De Salvo; A Ramirez-Rivera; J Almeida; L Sichletidis; G nter Rapatz; John Kottakis
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
Chest 2001;119(5):1347-56.
2001: A Eliraz; A Ramirez-Rivera; P Ferranti; R Holzer; J M García; C Turcotte; G nter Rapatz; P Pfister; Tim Overend; John Kottakis
Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
International journal of clinical practice 2001;55(3):164-70.
1999: Jan Lötvall; A Mellén; Pernilla Arvidsson; Mona Palmqvist; P Radielovic; John Kottakis; P Pfister
Similar bronchodilation with formoterol delivered by aerolizer or turbuhaler.
Canadian respiratory journal : journal of the Canadian Thoracic Society 1999;6(5):412-6.
1999: Demosthenes Bouros; N Bachlitzanakis; John Kottakis; P Pfister; Vlassis Polychronopoulos; Emmanuel Papadakis; Stavros H Constantopoulos; Marios E Froudarakis; L Sichletidis; Nikolaos Siafakas
Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1999;14(3):627-32.
1999: L Sichletidis; John Kottakis; S Marcou; T C Constantinidis; A Antoniades
Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.
International journal of clinical practice 1999;53(3):185-8.